Dr Shengyang Wu, MD | |
301 W Huntington Dr Ste 120, Arcadia, CA 91007-3487 | |
(626) 574-3657 | |
(626) 898-8016 |
Full Name | Dr Shengyang Wu |
---|---|
Gender | Male |
Speciality | Radiation Oncology |
Experience | 10 Years |
Location | 301 W Huntington Dr Ste 120, Arcadia, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083032023 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0001X | Radiology - Radiation Oncology | A186136 (California) | Primary |
2085R0001X | Radiology - Radiation Oncology | 25MA10597000 (New Jersey) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Holy Name Medical Center | Teaneck, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
City Of Hope Medical Foundation | 3779751656 | 686 |
News Archive
Scientists who search for new pesticides for use in humanity's battle of the bugs and other threats to the food supply have been learning lessons from Mother Nature, according to a new analysis. It concludes that more than two out of every three new pesticide active ingredients approved in recent years had roots in natural substances produced in plants or animals. The article appears in ACS' Journal of Natural Products.
The Queensland Government has tightened pool safety laws and launched a pool safety education campaign. From now on all pool fences will have to comply with new safety requirements within five years. Safety inspections will be required if a property is sold or rented before then. This is the second phase of tough new pool laws. The laws also give safety inspectors greater powers of entry to undertake checks.
Silence Therapeutics plc, a leading RNA interference (RNAi) therapeutics company, today announced that it has entered into an agreement with Mirna Therapeutics Inc., a biopharmaceutical company pioneering microRNA-based therapeutics for cancer, to assess the delivery capabilities of Silence's proprietary AtuPLEX and DBTC delivery systems for Mirna's novel microRNAs.
Major League Baseball players are putting their bats to work once again to help strike out prostate cancer as part of the Prostate Cancer Foundation's 14th Annual Home Run Challenge. The Home Run Challenge, a partnership between the Prostate Cancer Foundation, Major League Baseball and the Major League Baseball Players Association, begins today and runs through Father's Day, June 20, 2010.
A new study by Loyola University Health System researchers could lead to alternative treatments that would shrink skin cancer tumors with drugs. The drugs would work by turning on a gene that prevents skin cells from becoming cancerous, said senior author Mitchell Denning, Ph.D.
› Verified 9 days ago
Entity Name | City Of Hope Medical Foundation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1871886366 PECOS PAC ID: 3779751656 Enrollment ID: O20110720000244 |
News Archive
Scientists who search for new pesticides for use in humanity's battle of the bugs and other threats to the food supply have been learning lessons from Mother Nature, according to a new analysis. It concludes that more than two out of every three new pesticide active ingredients approved in recent years had roots in natural substances produced in plants or animals. The article appears in ACS' Journal of Natural Products.
The Queensland Government has tightened pool safety laws and launched a pool safety education campaign. From now on all pool fences will have to comply with new safety requirements within five years. Safety inspections will be required if a property is sold or rented before then. This is the second phase of tough new pool laws. The laws also give safety inspectors greater powers of entry to undertake checks.
Silence Therapeutics plc, a leading RNA interference (RNAi) therapeutics company, today announced that it has entered into an agreement with Mirna Therapeutics Inc., a biopharmaceutical company pioneering microRNA-based therapeutics for cancer, to assess the delivery capabilities of Silence's proprietary AtuPLEX and DBTC delivery systems for Mirna's novel microRNAs.
Major League Baseball players are putting their bats to work once again to help strike out prostate cancer as part of the Prostate Cancer Foundation's 14th Annual Home Run Challenge. The Home Run Challenge, a partnership between the Prostate Cancer Foundation, Major League Baseball and the Major League Baseball Players Association, begins today and runs through Father's Day, June 20, 2010.
A new study by Loyola University Health System researchers could lead to alternative treatments that would shrink skin cancer tumors with drugs. The drugs would work by turning on a gene that prevents skin cells from becoming cancerous, said senior author Mitchell Denning, Ph.D.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Shengyang Wu, MD Po Box 512185, Los Angeles, CA 90051-0185 Ph: () - | Dr Shengyang Wu, MD 301 W Huntington Dr Ste 120, Arcadia, CA 91007-3487 Ph: (626) 574-3657 |
News Archive
Scientists who search for new pesticides for use in humanity's battle of the bugs and other threats to the food supply have been learning lessons from Mother Nature, according to a new analysis. It concludes that more than two out of every three new pesticide active ingredients approved in recent years had roots in natural substances produced in plants or animals. The article appears in ACS' Journal of Natural Products.
The Queensland Government has tightened pool safety laws and launched a pool safety education campaign. From now on all pool fences will have to comply with new safety requirements within five years. Safety inspections will be required if a property is sold or rented before then. This is the second phase of tough new pool laws. The laws also give safety inspectors greater powers of entry to undertake checks.
Silence Therapeutics plc, a leading RNA interference (RNAi) therapeutics company, today announced that it has entered into an agreement with Mirna Therapeutics Inc., a biopharmaceutical company pioneering microRNA-based therapeutics for cancer, to assess the delivery capabilities of Silence's proprietary AtuPLEX and DBTC delivery systems for Mirna's novel microRNAs.
Major League Baseball players are putting their bats to work once again to help strike out prostate cancer as part of the Prostate Cancer Foundation's 14th Annual Home Run Challenge. The Home Run Challenge, a partnership between the Prostate Cancer Foundation, Major League Baseball and the Major League Baseball Players Association, begins today and runs through Father's Day, June 20, 2010.
A new study by Loyola University Health System researchers could lead to alternative treatments that would shrink skin cancer tumors with drugs. The drugs would work by turning on a gene that prevents skin cells from becoming cancerous, said senior author Mitchell Denning, Ph.D.
› Verified 9 days ago
Dr. Juan Carlos Echeverria, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 300 W Huntington Dr, Arcadia, CA 91007 Phone: 626-898-8004 Fax: 626-898-8235 | |
Mr. Leon Edward Lis, MD Radiology Medicare: Medicare Enrolled Practice Location: 612 W Duarte Rd, Ste 101, Arcadia, CA 91007 Phone: 626-445-4850 Fax: 626-445-0482 | |
Dr. Brian H Lee, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 612 W Duarte Rd Ste 101, Arcadia, CA 91007 Phone: 626-447-0035 | |
Mr. Wilson Shen Wong, MD Radiology Medicare: Medicare Enrolled Practice Location: 300 W Huntington Dr, Arcadia, CA 91007 Phone: 626-898-8610 | |
Thomas Zung, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1630 La Ramada Ave, Arcadia, CA 91006 Phone: 626-447-4477 Fax: 626-355-6962 | |
Mr. Jose Solomon Tandoc, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 612 W Duarte Rd Ste 101, Arcadia Radiology Medical Group, Arcadia, CA 91007 Phone: 626-445-4850 Fax: 626-445-0482 |